Outbreak Investigation of Salmonella: Moringa Leaf Powder

December 4, 2025

The FDA and CDC, in collaboration with state and local partners, investigated illnesses in a multistate outbreak of Salmonella Richmond infections linked to a single lot (Batch No.: VFD/ORG/MORP/L/24 with the best by date (BBD) of November 2027) of moringa leaf powder supplied to the United States by Vallon Farmdirect PVT LTD of Johdpur, India.

As of December 4, 2025, CDC has declared the outbreak to be over. A total of 11 people infected with the outbreak strain of Salmonella were reported from 7 states. Illnesses started on dates ranging from May 12, 2025, to September 4, 2025. Of 11 people with information available, 3 were hospitalized. No deaths were reported.

As part of this investigation, FDA and state partners collected product samples for laboratory analysis. Positive sample results from this investigation are included on the advisory.

Recalled product should no longer be on the market for sale; however, this product has a long shelf life. Consumers should check their homes for recalled products and throw these products away or return them to the place of purchase. FDA’s outbreak investigation is complete.

Read the full update.

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.

R.G. Client

I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.

Mike H. Client

Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.

Dr. Sastry Client

I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.

Claire P. Client